A case of tuberculous uveitis treated by topical corticosteroid Kei Homma 1 , Sakiko Goto 1 , Noriko Mochizuki 1 , Hidetoshi Yamashita 1 1Dept of Ophthalmol and Vis Sci, Yamagata Univ Fac of Med pp.203-208
Published Date 2013/2/15
DOI https://doi.org/10.11477/mf.1410104604
  • Abstract
  • Look Inside
  • Reference

Abstract. Background:Difluprednate ophthalmic solution(Durezol®)is claimed to be an anti-inflammatory agent with high intraocular penetration. Purpose:To report a case of presumed tuberculous uveitis with retinal vasculitis treated with diflupredonate ophthalmic solution. Case:A 58-year-old male presented with blurring of his right eye since 2 months before. He had received surgery for thyroid carcinoma 15 years before. Findings:Corrected visual acuity was 0.01 right and 1.2 left. The right eye showed signs of inflammation in the anterior chamber, vitreous opacity, multiple retinal hemorrhages, and perivasculitis. He was positive to tuberculin skin test and QuantiFERON TB-2G. He was diagnosed with presumed tuberculous uveitis and started receiving peroral antituberculous medications. Ocular signs of inflammation subsided 2 months later leaving macular edema. Instillation of 0.05% difluprednate ophthalmic solution was followed by improvement of macular edema after 3 months with visual acuity of 0.2. There has been no recurrence for 8 months until present. Conclusion:Instillation of difluprednate ophthalmic solution was followed by improvement of macular edema in a case of retinal vasculitis.

Copyright © 2013, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院